BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33004605)

  • 1. Co-occurrence of apathy and impulse control disorders in Parkinson disease.
    Scott BM; Eisinger RS; Burns MR; Lopes J; Okun MS; Gunduz A; Bowers D
    Neurology; 2020 Nov; 95(20):e2769-e2780. PubMed ID: 33004605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apathy and impulse control disorders in Parkinson's disease: a direct comparison.
    Leroi I; Andrews M; McDonald K; Harbishettar V; Elliott R; Byrne EJ; Burns A
    Parkinsonism Relat Disord; 2012 Feb; 18(2):198-203. PubMed ID: 22035735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.
    Sierra M; Carnicella S; Strafella AP; Bichon A; Lhommée E; Castrioto A; Chabardes S; Thobois S; Krack P
    J Parkinsons Dis; 2015; 5(3):625-36. PubMed ID: 25870025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-Sectional and Longitudinal Association of Clinical and Neurocognitive Factors With Apathy in Patients With Parkinson Disease.
    Le Heron C; Horne KL; MacAskill MR; Livingstone L; Melzer TR; Myall D; Pitcher T; Dalrymple-Alford J; Anderson T; Harrison S
    Neurology; 2024 Jun; 102(12):e209301. PubMed ID: 38830182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulse control behaviors and apathy commonly co-occur in de novo Parkinson's disease and predict the incidence of levodopa-induced dyskinesia.
    Zhang Y; Zhu XB; Gan J; Song L; Qi C; Wu N; Wan Y; Hou M; Liu Z
    J Affect Disord; 2024 Apr; 351():895-903. PubMed ID: 38342317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of neuropsychiatric disorders in drug-naive subjects with Parkinson's disease (PD)].
    Isais-Millán S; Piña-Fuentes D; Guzmán-Astorga C; Cervantes-Arriaga A; Rodríguez-Violante M
    Gac Med Mex; 2016; 152(3):357-63. PubMed ID: 27335192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of psychiatric symptoms and global cognition in early Parkinson disease.
    de la Riva P; Smith K; Xie SX; Weintraub D
    Neurology; 2014 Sep; 83(12):1096-103. PubMed ID: 25128183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson's Disease.
    Waskowiak P; Koppelmans V; Ruitenberg MFL
    J Parkinsons Dis; 2022; 12(2):689-697. PubMed ID: 34897102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms precede cognitive impairment in de novo Parkinson's disease patients: Analysis of the PPMI cohort.
    Jones JD; Kurniadi NE; Kuhn TP; Szymkowicz SM; Bunch J; Rahmani E
    Neuropsychology; 2019 Nov; 33(8):1111-1120. PubMed ID: 31343240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risky decision-making and affective features of impulse control disorders in Parkinson's disease.
    Martini A; Ellis SJ; Grange JA; Tamburin S; Dal Lago D; Vianello G; Edelstyn NMJ
    J Neural Transm (Vienna); 2018 Feb; 125(2):131-143. PubMed ID: 29119257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric Symptoms in Clinically Defined Parkinson's Disease: An Updated Review of Literature.
    Macías-García P; Rashid-López R; Cruz-Gómez ÁJ; Lozano-Soto E; Sanmartino F; Espinosa-Rosso R; González-Rosa JJ
    Behav Neurol; 2022; 2022():1213393. PubMed ID: 35586201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression as a Risk Factor for Impulse Control Disorders in Parkinson Disease.
    Marín-Lahoz J; Sampedro F; Martinez-Horta S; Pagonabarraga J; Kulisevsky J
    Ann Neurol; 2019 Nov; 86(5):762-769. PubMed ID: 31415102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carer burden in apathy and impulse control disorders in Parkinson's disease.
    Leroi I; Harbishettar V; Andrews M; McDonald K; Byrne EJ; Burns A
    Int J Geriatr Psychiatry; 2012 Feb; 27(2):160-6. PubMed ID: 21462269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of dopamine agonist use with impulse control disorders in Parkinson disease.
    Weintraub D; Siderowf AD; Potenza MN; Goveas J; Morales KH; Duda JE; Moberg PJ; Stern MB
    Arch Neurol; 2006 Jul; 63(7):969-73. PubMed ID: 16831966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.
    Wu K; Politis M; O'Sullivan SS; Lawrence AD; Warsi S; Bose S; Lees AJ; Piccini P
    J Neurol; 2015 Jun; 262(6):1504-14. PubMed ID: 25893253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety and Depression Are Better Correlates of Parkinson's Disease Quality of Life Than Apathy.
    Jones JD; Butterfield LC; Song W; Lafo J; Mangal P; Okun MS; Bowers D
    J Neuropsychiatry Clin Neurosci; 2015; 27(3):213-8. PubMed ID: 25162776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulsivity and apathy in Parkinson's disease.
    Sinha N; Manohar S; Husain M
    J Neuropsychol; 2013 Sep; 7(2):255-83. PubMed ID: 23621377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.